We are live on ! Find out more
BG

Baupost Group Portfolio holdings

AUM $5.12B
1-Year Est. Return 15.99%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+15.99%
3 Year Est. Return
+34.54%
5 Year Est. Return
+18.79%
10 Year Est. Return
+138.91%
AUM
$9.06B
AUM Growth
+$225M
Cap. Flow
-$721M
Cap. Flow %
-7.96%
Top 10 Hldgs %
71.27%
Holding
35
New
3
Increased
4
Reduced
7
Closed
4

Top Buys

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$194M
2
LBTYK icon
Liberty Global Class C
LBTYK
+$190M
3
HPQ icon
HP
HPQ
+$189M
4
EBAY icon
eBay
EBAY
+$121M
5
MCK icon
McKesson
MCK
+$41.2M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$344M
2
QRVO icon
Qorvo
QRVO
+$283M
3
TAK icon
Takeda Pharmaceutical
TAK
+$162M
4
NUAN
Nuance Communications, Inc.
NUAN
+$120M
5
SYF icon
Synchrony
SYF
+$71.6M

Sector Composition

Rank Sector Weight
1 Communication Services 38.84%
2 Technology 17.35%
3 Healthcare 13.47%
4 Consumer Discretionary 8.23%
5 Energy 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CARS icon
26
Cars.com
CARS
$725M
$33.1M 0.37%
2,707,313
-292,687
-10% -$3.42M
TMQ
27
Trilogy Metals
TMQ
$508M
$31.5M 0.35%
12,182,568
– –
CZR icon
28
Caesars Entertainment
CZR
$6.07B
$23.2M 0.26%
+389,026
New +$19.3M
MDR
29
DELISTED
McDermott International
MDR
$535K 0.01%
+805,693
New +$1.03M
AR icon
30
Antero Resources
AR
$10.9B
– –
-21,087,791
Closed -$63.7M
GOSS icon
31
Gossamer Bio
GOSS
$94.2M
– –
-967,171
Closed -$15.9M
TAK icon
32
Takeda Pharmaceutical
TAK
$56.7B
– –
-9,434,803
Closed -$162M
PRTK
33
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-2,394,498
Closed -$10.3M
1
2

Similar funds

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $5.13B AUM 22.98% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return

Baupost Group's Q4 2019 Portfolio in Review

As of Q4 2019, Baupost Group held 35 positions worth $9.06B, up 2.5% from $8.83B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Baupost Group withdrew a net $721M in Q4 2019, closing 4 positions and reducing 7 holdings. Its most notable exit was Takeda Pharmaceutical, an estimated $162M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 39% of assets, up from 34% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Baupost Group opened a new position in HP worth $206M.

  • Baupost Group's largest Q4 2019 buy was HP: 10,000,000 shares worth $206M.
  • Baupost Group added most to Paramount Global Class B in Q4 2019, an estimated $194M increase.
  • Baupost Group's biggest Q4 2019 reduction was Bristol-Myers Squibb, cutting an estimated $344M.
  • Baupost Group fully exited Takeda Pharmaceutical in Q4 2019, selling an estimated $162M.
  • Baupost Group's ten largest holdings make up 71% of its $9.06B portfolio in Q4 2019.
  • Baupost Group opened 3 new positions and closed 4 in Q4 2019.
  • Baupost Group's portfolio value rose 2.5% quarter-over-quarter to $9.06B.

Based on Baupost Group's 13F filing for Q4 2019, filed 13 Feb 2020.